+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Trials Market Research Report by Design, Phase, Indication, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5134269
  • Report
  • October 2021
  • Region: Global
  • 198 pages
  • 360iResearch™
UP TO OFF
until Jan 01st 2022
Global Clinical Trials Market is Projected to Reach USD 49,745.40 Million by 2026, Registering a CAGR of 8.96%

FEATURED COMPANIES

  • Atlant Clinical Ltd.
  • Clinipace
  • Eli Lilly and Company
  • Icon PLC
  • IQVIA Holdings, Inc.
  • Novo Nordisk A/S
  • MORE
The Global Clinical Trials Market size was estimated at USD 29,712.55 million in 2020, is expected to reach USD 32,276.86 million in 2021, and projected to grow at a CAGR of 8.96% reaching USD 49,745.40 million by 2026.



Market Statistics


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage


This research report categorizes the Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Design, the market was studied across Interventional Study and Observational Study. The Interventional Study is further studied across Adaptive Clinical Trial, Non-randomized Control Trial, and Randomized Control Trial. The Observational Study is further studied across Case Control Study, Cohort Study, Cross Sectional Study, and Ecological Study.
  • Based on Phase, the market was studied across Phase I, Phase II, Phase III, and Phase IV.
  • Based on Indication, the market was studied across Autoimmune/Inflammation, Cardiovascular, CNS condition, Diabetes, Infectious Diseases, Obesity, Oncology, and Pain management.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The analyst's ongoing research amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Market, including Accell Clinical Research, LLC, Atlant Clinical Ltd., Charles River Laboratories International, Inc., Clinipace, Eli Lilly and Company, Icon PLC, IQVIA Holdings, Inc., Novo Nordisk A/S, Parexel International Corporation, Pfizer Inc., ProPharma Group Holdings, LLC, SGS S.A., SIRO Clinpharm Private Limited, Syneos Health, Inc., Thermo Fisher Scientific Inc., and Wuxi AppTec Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trials Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trials Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trials Market?
6. What is the market share of the leading vendors in the Global Clinical Trials Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Trials Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Atlant Clinical Ltd.
  • Clinipace
  • Eli Lilly and Company
  • Icon PLC
  • IQVIA Holdings, Inc.
  • Novo Nordisk A/S
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising Prevalence of Diseases
5.2.2. Shift Towards Patient Centric Clinical Trials
5.2.3. Improved Clinical Trails Due to CRO Consolidation
5.2.4. Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
5.2.5. Increased Focus on Drug Development
5.2.6. Globalization of Clinical Trials and Harmonization of Regulations
5.3. Restraints
5.3.1. Dearth of Skilled Clinical Research Professional
5.3.2. Increased Cost of Drug Development and Clinical Trials
5.4. Opportunities
5.4.1. Demand for Clinical Trials in the Emerging Economies
5.4.2. Outsourcing of Clinical Trial Activity
5.4.3. Increased Focus on Development and Commercialization of Generics and Biologics
5.4.4. Regulatory Approvals in Emerging Markets
5.5. Challenges
5.5.1. Stringent Regulations for Patient Enrollment
5.5.2. Cross border Logistics Challenges Challenging Clinical trials

6. Clinical Trials Market, by Design
6.1. Introduction
6.2. Interventional Study
6.2.1. Adaptive Clinical Trial
6.2.2. Non-randomized Control Trial
6.2.3. Randomized Control Trial
6.3. Observational Study
6.3.1. Case Control Study
6.3.2. Cohort Study
6.3.3. Cross Sectional Study
6.3.4. Ecological Study

7. Clinical Trials Market, by Phase
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV

8. Clinical Trials Market, by Indication
8.1. Introduction
8.2. Autoimmune/Inflammation
8.3. Cardiovascular
8.4. CNS condition
8.5. Diabetes
8.6. Infectious Diseases
8.7. Obesity
8.8. Oncology
8.9. Pain management

9. Americas Clinical Trials Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Clinical Trials Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Clinical Trials Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Accell Clinical Research, LLC
13.2. Atlant Clinical Ltd.
13.3. Charles River Laboratories International, Inc.
13.4. Clinipace
13.5. Eli Lilly and Company
13.6. Icon PLC
13.7. IQVIA Holdings, Inc.
13.8. Novo Nordisk A/S
13.9. Parexel International Corporation
13.10. Pfizer Inc.
13.11. ProPharma Group Holdings, LLC
13.12. SGS S.A.
13.13. SIRO Clinpharm Private Limited
13.14. Syneos Health, Inc.
13.15. Thermo Fisher Scientific Inc.
13.16. Wuxi AppTec Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
Figure 1. Global Clinical Trials Market Size, 2020 vs 2026 (USD Million)
Figure 2. Global Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 3. Global Clinical Trials Market: Market Dynamics
Figure 4. Global Clinical Trials Market Size, by Design, 2020 vs 2026 (%)
Figure 5. Global Clinical Trials Market Size, by Design, 2020 vs 2026 (USD Million)
Figure 6. Competitive Strategic Window for Global Clinical Trials Market Size, by Design, 2026
Figure 7. Global Clinical Trials Market Size, by Interventional Study, 2018-2026 (USD Million)
Figure 8. Global Clinical Trials Market Size, by Interventional Study, by Region, 2020 vs 2026 (USD Million)
Figure 9. Global Clinical Trials Market Size, by Adaptive Clinical Trial, 2018-2026 (USD Million)
Figure 10. Global Clinical Trials Market Size, by Adaptive Clinical Trial, by Region, 2020 vs 2026 (USD Million)
Figure 11. Global Clinical Trials Market Size, by Non-Randomized Control Trial, 2018-2026 (USD Million)
Figure 12. Global Clinical Trials Market Size, by Non-Randomized Control Trial, by Region, 2020 vs 2026 (USD Million)
Figure 13. Global Clinical Trials Market Size, by Randomized Control Trial, 2018-2026 (USD Million)
Figure 14. Global Clinical Trials Market Size, by Randomized Control Trial, by Region, 2020 vs 2026 (USD Million)
Figure 15. Global Clinical Trials Market Size, by Observational Study, 2018-2026 (USD Million)
Figure 16. Global Clinical Trials Market Size, by Observational Study, by Region, 2020 vs 2026 (USD Million)
Figure 17. Global Clinical Trials Market Size, by Case Control Study, 2018-2026 (USD Million)
Figure 18. Global Clinical Trials Market Size, by Case Control Study, by Region, 2020 vs 2026 (USD Million)
Figure 19. Global Clinical Trials Market Size, by Cohort Study, 2018-2026 (USD Million)
Figure 20. Global Clinical Trials Market Size, by Cohort Study, by Region, 2020 vs 2026 (USD Million)
Figure 21. Global Clinical Trials Market Size, by Cross Sectional Study, 2018-2026 (USD Million)
Figure 22. Global Clinical Trials Market Size, by Cross Sectional Study, by Region, 2020 vs 2026 (USD Million)
Figure 23. Global Clinical Trials Market Size, by Ecological Study, 2018-2026 (USD Million)
Figure 24. Global Clinical Trials Market Size, by Ecological Study, by Region, 2020 vs 2026 (USD Million)
Figure 25. Global Clinical Trials Market Size, by Phase, 2020 vs 2026 (%)
Figure 26. Global Clinical Trials Market Size, by Phase, 2020 vs 2026 (USD Million)
Figure 27. Competitive Strategic Window for Global Clinical Trials Market Size, by Phase, 2026
Figure 28. Global Clinical Trials Market Size, by Phase I, 2018-2026 (USD Million)
Figure 29. Global Clinical Trials Market Size, by Phase I, by Region, 2020 vs 2026 (USD Million)
Figure 30. Global Clinical Trials Market Size, by Phase Ii, 2018-2026 (USD Million)
Figure 31. Global Clinical Trials Market Size, by Phase Ii, by Region, 2020 vs 2026 (USD Million)
Figure 32. Global Clinical Trials Market Size, by Phase Iii, 2018-2026 (USD Million)
Figure 33. Global Clinical Trials Market Size, by Phase Iii, by Region, 2020 vs 2026 (USD Million)
Figure 34. Global Clinical Trials Market Size, by Phase Iv, 2018-2026 (USD Million)
Figure 35. Global Clinical Trials Market Size, by Phase Iv, by Region, 2020 vs 2026 (USD Million)
Figure 36. Global Clinical Trials Market Size, by Indication, 2020 vs 2026 (%)
Figure 37. Global Clinical Trials Market Size, by Indication, 2020 vs 2026 (USD Million)
Figure 38. Competitive Strategic Window for Global Clinical Trials Market Size, by Indication, 2026
Figure 39. Global Clinical Trials Market Size, by Autoimmune/Inflammation, 2018-2026 (USD Million)
Figure 40. Global Clinical Trials Market Size, by Autoimmune/Inflammation, by Region, 2020 vs 2026 (USD Million)
Figure 41. Global Clinical Trials Market Size, by Cardiovascular, 2018-2026 (USD Million)
Figure 42. Global Clinical Trials Market Size, by Cardiovascular, by Region, 2020 vs 2026 (USD Million)
Figure 43. Global Clinical Trials Market Size, by Cns Condition, 2018-2026 (USD Million)
Figure 44. Global Clinical Trials Market Size, by Cns Condition, by Region, 2020 vs 2026 (USD Million)
Figure 45. Global Clinical Trials Market Size, by Diabetes, 2018-2026 (USD Million)
Figure 46. Global Clinical Trials Market Size, by Diabetes, by Region, 2020 vs 2026 (USD Million)
Figure 47. Global Clinical Trials Market Size, by Infectious Diseases, 2018-2026 (USD Million)
Figure 48. Global Clinical Trials Market Size, by Infectious Diseases, by Region, 2020 vs 2026 (USD Million)
Figure 49. Global Clinical Trials Market Size, by Obesity, 2018-2026 (USD Million)
Figure 50. Global Clinical Trials Market Size, by Obesity, by Region, 2020 vs 2026 (USD Million)
Figure 51. Global Clinical Trials Market Size, by Oncology, 2018-2026 (USD Million)
Figure 52. Global Clinical Trials Market Size, by Oncology, by Region, 2020 vs 2026 (USD Million)
Figure 53. Global Clinical Trials Market Size, by Pain Management, 2018-2026 (USD Million)
Figure 54. Global Clinical Trials Market Size, by Pain Management, by Region, 2020 vs 2026 (USD Million)
Figure 55. Americas Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 56. Argentina Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 57. Brazil Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 58. Canada Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 59. Mexico Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 60. United States Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 61. Asia-Pacific Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 62. Australia Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 63. China Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 64. India Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 65. Indonesia Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 66. Japan Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 67. Malaysia Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 68. Philippines Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 69. Singapore Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 70. South Korea Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 71. Thailand Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 72. Europe, Middle East & Africa Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 73. France Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 74. Germany Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 75. Italy Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 76. Netherlands Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 77. Qatar Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 78. Russia Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 79. Saudi Arabia Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 80. South Africa Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 81. Spain Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 82. United Arab Emirates Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 83. United Kingdom Clinical Trials Market Size, 2018-2026 (USD Million)
Figure 84. Global Clinical Trials Market: FPNV Positioning Matrix
Figure 85. Global Clinical Trials Market: Share, by Key Player, 2020
Figure 86. Competitive Scenario Analysis in Global Clinical Trials Market, by Type

List of Tables
Table 1. Global Clinical Trials Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016–2020
Table 3. Global Clinical Trials Market Size, 2018-2026 (USD Million)
Table 4. Global Clinical Trials Market Size, by Design, 2018-2026 (USD Million)
Table 5. Global Clinical Trials Market Size, by Interventional Study, by Region, 2018-2026 (USD Million)
Table 6. Global Clinical Trials Market Size, by Adaptive Clinical Trial, by Region, 2018-2026 (USD Million)
Table 7. Global Clinical Trials Market Size, by Non-Randomized Control Trial, by Region, 2018-2026 (USD Million)
Table 8. Global Clinical Trials Market Size, by Randomized Control Trial, by Region, 2018-2026 (USD Million)
Table 9. Global Clinical Trials Market Size, by Observational Study, by Region, 2018-2026 (USD Million)
Table 10. Global Clinical Trials Market Size, by Case Control Study, by Region, 2018-2026 (USD Million)
Table 11. Global Clinical Trials Market Size, by Cohort Study, by Region, 2018-2026 (USD Million)
Table 12. Global Clinical Trials Market Size, by Cross Sectional Study, by Region, 2018-2026 (USD Million)
Table 13. Global Clinical Trials Market Size, by Ecological Study, by Region, 2018-2026 (USD Million)
Table 14. Global Clinical Trials Market Size, by Phase, 2018-2026 (USD Million)
Table 15. Global Clinical Trials Market Size, by Phase I, by Region, 2018-2026 (USD Million)
Table 16. Global Clinical Trials Market Size, by Phase Ii, by Region, 2018-2026 (USD Million)
Table 17. Global Clinical Trials Market Size, by Phase Iii, by Region, 2018-2026 (USD Million)
Table 18. Global Clinical Trials Market Size, by Phase Iv, by Region, 2018-2026 (USD Million)
Table 19. Global Clinical Trials Market Size, by Indication, 2018-2026 (USD Million)
Table 20. Global Clinical Trials Market Size, by Autoimmune/Inflammation, by Region, 2018-2026 (USD Million)
Table 21. Global Clinical Trials Market Size, by Cardiovascular, by Region, 2018-2026 (USD Million)
Table 22. Global Clinical Trials Market Size, by Cns Condition, by Region, 2018-2026 (USD Million)
Table 23. Global Clinical Trials Market Size, by Diabetes, by Region, 2018-2026 (USD Million)
Table 24. Global Clinical Trials Market Size, by Infectious Diseases, by Region, 2018-2026 (USD Million)
Table 25. Global Clinical Trials Market Size, by Obesity, by Region, 2018-2026 (USD Million)
Table 26. Global Clinical Trials Market Size, by Oncology, by Region, 2018-2026 (USD Million)
Table 27. Global Clinical Trials Market Size, by Pain Management, by Region, 2018-2026 (USD Million)
Table 28. Americas Clinical Trials Market Size, 2018-2026 (USD Million)
Table 29. Argentina Clinical Trials Market Size, 2018-2026 (USD Million)
Table 30. Brazil Clinical Trials Market Size, 2018-2026 (USD Million)
Table 31. Canada Clinical Trials Market Size, 2018-2026 (USD Million)
Table 32. Mexico Clinical Trials Market Size, 2018-2026 (USD Million)
Table 33. United States Clinical Trials Market Size, 2018-2026 (USD Million)
Table 34. Asia-Pacific Clinical Trials Market Size, 2018-2026 (USD Million)
Table 35. Australia Clinical Trials Market Size, 2018-2026 (USD Million)
Table 36. China Clinical Trials Market Size, 2018-2026 (USD Million)
Table 37. India Clinical Trials Market Size, 2018-2026 (USD Million)
Table 38. Indonesia Clinical Trials Market Size, 2018-2026 (USD Million)
Table 39. Japan Clinical Trials Market Size, 2018-2026 (USD Million)
Table 40. Malaysia Clinical Trials Market Size, 2018-2026 (USD Million)
Table 41. Philippines Clinical Trials Market Size, 2018-2026 (USD Million)
Table 42. Singapore Clinical Trials Market Size, 2018-2026 (USD Million)
Table 43. South Korea Clinical Trials Market Size, 2018-2026 (USD Million)
Table 44. Thailand Clinical Trials Market Size, 2018-2026 (USD Million)
Table 45. Europe, Middle East & Africa Clinical Trials Market Size, 2018-2026 (USD Million)
Table 46. France Clinical Trials Market Size, 2018-2026 (USD Million)
Table 47. Germany Clinical Trials Market Size, 2018-2026 (USD Million)
Table 48. Italy Clinical Trials Market Size, 2018-2026 (USD Million)
Table 49. Netherlands Clinical Trials Market Size, 2018-2026 (USD Million)
Table 50. Qatar Clinical Trials Market Size, 2018-2026 (USD Million)
Table 51. Russia Clinical Trials Market Size, 2018-2026 (USD Million)
Table 52. Saudi Arabia Clinical Trials Market Size, 2018-2026 (USD Million)
Table 53. South Africa Clinical Trials Market Size, 2018-2026 (USD Million)
Table 54. Spain Clinical Trials Market Size, 2018-2026 (USD Million)
Table 55. United Arab Emirates Clinical Trials Market Size, 2018-2026 (USD Million)
Table 56. United Kingdom Clinical Trials Market Size, 2018-2026 (USD Million)
Table 57. Global Clinical Trials Market: Scores
Table 58. Global Clinical Trials Market: Business Strategy
Table 59. Global Clinical Trials Market: Product Satisfaction
Table 60. Global Clinical Trials Market: Ranking
Table 61. Global Clinical Trials Market: Share, by Key Player, 2020
Table 62. Global Clinical Trials Market: Merger & Acquisition
Table 63. Global Clinical Trials Market: Agreement, Collaboration & Partnership
Table 64. Global Clinical Trials Market: New Product Launch & Enhancement
Table 65. Global Clinical Trials Market: Investment & Funding
Table 66. Global Clinical Trials Market: Award, Recognition & Expansion
Table 67. Global Clinical Trials Market: License & Pricing
Note: Product cover images may vary from those shown
  • Accell Clinical Research, LLC
  • Atlant Clinical Ltd.
  • Charles River Laboratories International, Inc.
  • Clinipace
  • Eli Lilly and Company
  • Icon PLC
  • IQVIA Holdings, Inc.
  • Novo Nordisk A/S
  • Parexel International Corporation
  • Pfizer Inc.
  • ProPharma Group Holdings, LLC
  • SGS S.A.
  • SIRO Clinpharm Private Limited
  • Syneos Health, Inc.
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll